Related Experiment Video
Updated: Jun 1, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin
Hui Yang1, Xiaoping Zhou, Xiaoyu Liu
1Department of Cellular and Genetic Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, PR China.
Abstract:
Mutations in the parkin gene are the most common cause of autosomal recessive Parkinson's disease (PD). As an E3-ubiquitin ligase, Parkin is associated with mitochondrial dynamics and mitophagy. Mortalin, a molecular chaperone, is located primarily in mitochondria, where it functions to maintain mitochondrial homeostasis and antagonize oxidative stress injury. A reduced expression level of mortalin has been observed in the affected brain regions of PD patients. Mortalin also interacts with a variety of PD-related proteins and plays an indispensible role in helping native protein refolding and importing proteins into the mitochondrial matrix. Thus, the main aims of the present study were to investigate mitochondrial dysfunction induced by knockdown of mortalin and to test whether Parkin overexpression could rescue this effect. We found that lentivirus-mediated knockdown of mortalin in HeLa cells resulted in a collapse of mitochondrial membrane potential, an abnormal accumulation of reactive oxygen species and apparent alterations in mitochondrial morphology under H(2)O(2)-induced stress conditions. Remarkably, Parkin overexpression rescued these mitochondrial abnormalities. In HeLa cells expressing Parkin, co-immunoprecipitation of endogenous mortalin and wild-type Parkin was detected when they were treated with carbonyl cyanide 3-chlorophenylhydrazone (CCCP). In conclusion, we indicate that the relatively decreased mortalin expression level and its impaired interaction with Parkin could affect its roles in mitochondrial function.
Insights
Parkin overexpression can rescue mitochondrial dysfunction caused by reduced mortalin levels, a key factor in Parkinson's disease (PD) pathogenesis. This suggests Parkin's therapeutic potential for PD by restoring mitochondrial health.
Area of Science:
- Mitochondrial Biology
- Neurodegenerative Diseases
- Molecular Chaperones
Background:
- Parkinson's disease (PD) is often linked to parkin gene mutations, affecting mitochondrial dynamics.
- Mortalin, a mitochondrial chaperone, maintains homeostasis and combats oxidative stress, with reduced levels observed in PD brains.
- Mortalin interacts with PD-related proteins and is crucial for protein refolding and mitochondrial import.
Purpose of the Study:
- To investigate mitochondrial dysfunction resulting from mortalin knockdown.
- To determine if Parkin overexpression can ameliorate mortalin knockdown-induced mitochondrial defects.
Main Methods:
- Lentivirus-mediated knockdown of mortalin in HeLa cells.
- Assessment of mitochondrial membrane potential, reactive oxygen species (ROS) accumulation, and morphology under oxidative stress.
- Overexpression of Parkin to evaluate rescue effects.
- Co-immunoprecipitation assays to detect Parkin-mortalin interactions.
Main Results:
- Mortalin knockdown led to mitochondrial membrane potential collapse, increased ROS, and altered morphology under H(2)O(2) stress.
- Parkin overexpression successfully rescued these mitochondrial abnormalities.
- Co-immunoprecipitation confirmed an interaction between endogenous mortalin and wild-type Parkin upon CCCP treatment.
Conclusions:
- Reduced mortalin levels and impaired Parkin interaction contribute to mitochondrial dysfunction in PD.
- Parkin plays a protective role in maintaining mitochondrial function, potentially through interaction with mortalin.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Parkinson Disease ll: Pathophysiology
